John Gebler
John Gebler
John Gebler is a Director of Biopharma Business Development at Waters. His experience includes R&D oversight and technical marketing business development. He has more than two decades of industrial analytical research experience in diagnostics, proteomics and biopharmaceutical characterization. He has developed and commercialized LC/MS system solutions for biopharmaceutical characterization, glycan characterization, and proteomics. He has more than 63 peer-reviewed publications and has presented at numerous invited lectures.

Posts by author

From the Results of Yesterday to the Biologic Drugs of Tomorrow

By April 11, 2018

A thousand small delays and opportunities for error can snowball over the years of a complex biotherapeutic drug development program. They add up to lost time and increased risk in an endeavor that has little tolerance for either. It doesn’t have to be this way.

Categories: Pharmaceutical
Tags: , , , ,

Biosimilars Intensify the Need for Harmonized Data

By February 28, 2018

To get the most out of recent innovations in biopharma development and QC such as multi-attribute monitoring, it’s time to better connect the systems that manage biopharma data. This series explores the what, the why, and the how of better biopharma data.

Categories: Pharmaceutical
Tags: , , , ,

Biopharma Data: Chaos or Harmony?

By January 29, 2018

If data can throw your biotherapeutic development program into chaos, it can also help move you forward. Let’s see how.

Categories: Pharmaceutical
Tags: , , , , , , , ,